GW Pharmaceuticals Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 1,161
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 12

GW Pharmaceuticals General Information

Description

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Other Healthcare Services
Parent Company
Primary Office
  • Sovereign House
  • Vision Park, Histon
  • Cambridge CB24 9BZ
  • England, United Kingdom
+44 01223 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GW Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GW Pharmaceuticals‘s full profile, request access.

Request a free trial

GW Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel thera
Pharmaceuticals
Cambridge, United Kingdom
1,161 As of 2020
00000
0.00 0000-00-00
000000&0 00000

0000000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut e
0000 000000000
Devon, PA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000 00

r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ul
0000000000000
Plano, TX
000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GW Pharmaceuticals Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zynerba Pharmaceuticals Formerly VC-backed Devon, PA 00 00000 00000000 00000
00000 000000000000 Formerly VC-backed Plano, TX 000 00.000 000000000 00.000
00000 000000000000 Corporation Vancouver, Canada 00 000.00 000000000 000.00
0000000 Formerly VC-backed Emeryville, CA 000 00000 000000 - 000 00000
0000 0000000000 Formerly VC-backed Long Beach, CA 0 00.000 00000000 00.000
You’re viewing 5 of 5 competitors. Get the full list »

GW Pharmaceuticals Executive Team (14)

Name Title Board Seat Contact Info
Justin Gover Chief Executive Officer & Board Member
Cristina Bando Chief Executive Officer
Scott Giacobello Chief Financial Officer
Tina Leger Chief Human Resources Officer
Douglas Snyder Chief Legal Officer
You’re viewing 5 of 14 executive team members. Get the full list »

GW Pharmaceuticals Board Members (8)

Name Representing Role Since
000000 00000 Self Board Member 000 0000
00000 00000 Self Board Member 000 0000
00000 000000 GW Pharmaceuticals Board Member 000 0000
00000000 000 Self Chairman & Founder 000 0000
00000 00000 Self Lead Independent Director and Deputy Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

GW Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GW Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GW Pharmaceuticals‘s full profile, request access.

Request a free trial